SRI spins off AI-powered drug discovery platform Synfini, Inc.
Synfini to commercialize and scale automated compound testing for rapid drug production
09-Oct-2023 -
SRI International announced it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development.
The technology brings together a suite of software and hardware ...
artificial intelligence
drug development
drug discovery
+2